Skip to content
Screener

Operating margin at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
26.5%+2.8pp
Amgen logo
AmgenAMGN
30%+6.5pp
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
17.6%+9.6pp
Shattuck Labs, Inc. logo
Shattuck Labs, Inc.STTK
-5,266.4%-9,520pp
TG Therapeutics logo
TG TherapeuticsTGTX
17.1%-1.9pp
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
-39,428.9%-49,795pp

Other financials

Income statement

See full
Revenue$396.0K-81.8%
Operating income-$46.5M-40.3%
Net income-$40.8M-38.4%
EPS (diluted)-$0.85-3.7%

Balance sheet

See full
Cash & equivalents$627.7M+6,105%
Total debt$1.4M-2.3%
Total equity$1.2B+266%
Total assets$1.2B+258%

Cash flow

See full
Operating cash flow-$28.9M-4.4%
CapEx$10.0K-58.3%
Free cash flow-$28.9M-4.4%

Valuation

See full
Market cap$6.15B+838%
Enterprise value$5.52B+758%

Profitability

See full
Net margin-4,104.8%-7,304pp
FCF margin-3,561.6%-6,956pp

Returns & leverage

See full
Return on equity-28.6%+3.2pp
Debt / equity0.0×
Current ratio29.3×+13.3×

Where this comes from

Calculated from Dianthus Therapeutics’s reported figures.

Based on trailing twelve months.

The source filing: Dianthus Therapeutics’s 10-Q, filed November 5, 2025. Open the filing →

Filed
Nov 5, 2025
Fiscal quarter
Q3 FY2025
Calendar quarter
Q3 2025
Accession
0001193125-25-266920

FAQ

What is Dianthus Therapeutics's operating margin?
Dianthus Therapeutics (DNTH) reported operating margin of -4,558.4% in Q3 2025.
How has Dianthus Therapeutics's operating margin changed year-over-year?
Dianthus Therapeutics's operating margin decreased by 195.0% year-over-year, from -1,545% to -4,558.4%.
What does operating margin mean?
Operating income as a percentage of revenue (trailing twelve months). Captures profitability from core operations after both cost of revenue and operating expenses, but before interest and taxes.

Ask your AI about Dianthus Therapeutics's operating margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude